Mitochondria-Dependent Apoptosis of Con A-Activated T Lymphocytes Induced by Asiatic Acid for Preventing Murine Fulminant Hepatitis

Selectively facilitating apoptosis of activated T cells is essential for the clearance of pathogenic injurious cells and subsequent efficient resolution of inflammation. However, few chemicals have been reported to trigger apoptosis of activated T cells for the treatment of hepatitis without affecting quiescent T cells. In the present study, we found that asiatic acid, a natural triterpenoid, selectively triggered apoptosis of concanavalin A (Con A)-activated T cells in a mitochondria-dependent manner indicated by the disruption of the mitochondrial transmembrane potential, release of cytochrome c from mitochondria to cytosol, caspases activation, and cleavage of PARP. In addition, asiatic acid also induced the cleavage of caspase 8 and Bid and augmented Fas expression in Con A-activated T cells. However, following activation of T cells from MRLlpr/lpr mice with mutation of Fas demonstrated a similar susceptibility to asiatic acid-induced apoptosis compared with normal T cells, suggesting that Fas-mediated death-receptor apoptotic pathway does not mainly contribute to asiatic acid-induced cell death. Furthermore, asiatic acid significantly alleviated Con A-induced T cell-dependent fulminant hepatitis in mice, as assessed by reduced serum transaminases, pro-inflammatory cytokines, and pathologic parameters. Consistent with the in vitro results, asiatic acid also induced apoptosis of activated CD4+ T cells in vivo. Taken together, our results demonstrated that the ability of asiatic acid to induce apoptosis of activated T cells and its potential use in the treatment of T-cell-mediated inflammatory diseases.

[1]  Jiaying Wu,et al.  Asiatic acid protects primary neurons against C2-ceramide-induced apoptosis. , 2012, European journal of pharmacology.

[2]  Man Liu,et al.  Immune mechanisms of Concanavalin A model of autoimmune hepatitis. , 2012, World journal of gastroenterology.

[3]  A. Strasser,et al.  Fas death receptor signalling: roles of Bid and XIAP , 2011, Cell Death and Differentiation.

[4]  H. Wajant,et al.  Therapeutic targeting of CD95 and the TRAIL death receptors. , 2011, Recent patents on anti-cancer drug discovery.

[5]  S. Bischoff,et al.  Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. , 2011, The Journal of nutritional biochemistry.

[6]  H. Schmidt,et al.  Insights into the molecular regulation of FasL (CD178) biology. , 2011, European journal of cell biology.

[7]  Qiang Xu,et al.  Erlotinib inhibits T-cell-mediated immune response via down-regulation of the c-Raf/ERK cascade and Akt signaling pathway. , 2011, Toxicology and applied pharmacology.

[8]  Qiang Xu,et al.  Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-gamma signaling in a murine model of inflammatory bowel disease. , 2010, Biochemical pharmacology.

[9]  Qiang Xu,et al.  Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis. , 2009, International immunopharmacology.

[10]  Yu Qin,et al.  Selective triggering of apoptosis of concanavalin A-activated T cells by fraxinellone for the treatment of T-cell-dependent hepatitis in mice. , 2009, Biochemical pharmacology.

[11]  Mi Kyeong Lee,et al.  Asiatic Acid Derivatives Protect Primary Cultures of Rat Hepatocytes against Carbon Tetrachloride-Induced Injury via the Cellular Antioxidant System , 2009, Natural product communications.

[12]  Y. Lou,et al.  Protective effects of asiatic acid against D-galactosamine/lipopolysaccharide-induced hepatotoxicity in hepatocytes and kupffer cells co-cultured system via redox-regulated leukotriene C4 synthase expression pathway. , 2009, European journal of pharmacology.

[13]  Jing Gao,et al.  Protective Effects of Asiatic Acid on Rotenone- or H2O2-Induced Injury in SH-SY5Y Cells , 2009, Neurochemical Research.

[14]  Qiang Xu,et al.  Dregea volubilis Ameliorates Concanavalin A-Induced Liver Injury by Facilitating Apoptosis of Activated T Cells , 2008, Experimental biology and medicine.

[15]  C. Fiocchi,et al.  Mucosal T cell proliferation and apoptosis in inflammatory bowel disease. , 2008, Current drug targets.

[16]  Inna N. Lavrik,et al.  Life and death in peripheral T cells , 2007, Nature Reviews Immunology.

[17]  S. Elmore Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[18]  L. Galluzzi,et al.  Mechanisms of cytochrome c release from mitochondria , 2006, Cell Death and Differentiation.

[19]  Chun-ching Lin,et al.  Asiatic Acid, a Triterpene, Induces Apoptosis and Cell Cycle Arrest through Activation of Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Pathways in Human Breast Cancer Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.

[20]  Qiang Xu,et al.  Hepatoprotective activity of Terminalia catappa L. leaves and its two triterpenoids , 2004, The Journal of pharmacy and pharmacology.

[21]  G. Shore,et al.  Regulation of apoptosis by endoplasmic reticulum pathways , 2003, Oncogene.

[22]  P. Krammer,et al.  The role of CD95 in the regulation of peripheral T‐cell apoptosis , 2003, Immunological reviews.

[23]  Yanan Zhu,et al.  Molecular mechanisms of activated T cell death in vivo. , 2002, Current opinion in immunology.

[24]  H. Wajant,et al.  The Fas Signaling Pathway: More Than a Paradigm , 2002, Science.

[25]  P. Krammer,et al.  Regulation of T cell apoptosis during the immune response. , 2002, Current molecular medicine.

[26]  G. Kroemer,et al.  Organelle-specific initiation of cell death pathways , 2001, Nature Cell Biology.

[27]  A. Hida,et al.  New disease-modifying antirheumatic drug 2 acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298) selectively augments activation-induced T cell death. , 2001, The Journal of laboratory and clinical medicine.

[28]  S. Sung,et al.  Asiatic acid derivatives protect cultured cortical neurons from glutamate-induced excitotoxicity. , 2000, Research communications in molecular pathology and pharmacology.

[29]  K. Sasaki,et al.  Protective effects of soyasapogenol A on liver injury mediated by immune response in a concanavalin A-induced hepatitis model. , 2000, European Journal of Pharmacology.

[30]  G. Servillo,et al.  Galectin‐1 exerts immunomodulatory and protective effects on concanavalin a–induced hepatitis in mice , 2000, Hepatology.

[31]  A. Wendel,et al.  A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.